Syneron Medical Ltd. (ELOS) is an Israel based developer and manufacturer of aesthetic medical products that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ELOS’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Syneron could be a solid choice for investors.
Current Quarter Estimates for ELOS
In the past 30 days, 1 estimate has gone higher for Syneron while no estimate moved lower in the same time period. The trend has been pretty favorable too, with estimates increasing from break even 30 days ago, to 2 cents today, a significant move.
Current Year Estimates for ELOS
Meanwhile, Syneron’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to none moving lower. The consensus estimate trend has also seen a boost for this time frame, increasing from 12 cents per share 30 days ago to 31 cents per share today, an improvement of 158.33%.
Bottom Line
The stock has also started to move higher lately, adding 9.57% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment